Welcome
Support Centre
02 September 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
National Adolescent Treatment Trial for Obesity in Kuwait
ISRCTN ISRCTN37457227
ClinicalTrials.gov identifier
Public title National Adolescent Treatment Trial for Obesity in Kuwait
Scientific title Randomised controlled trial of a behavioural treatment programme for obesity in Kuwaiti adolescents
Acronym NATTO
Serial number at source N/A
Study hypothesis To test whether parent-directed group-based behavioural treatment offers improved weight management over standard care.
Ethics approval Ethics Committee for Medical Research, Ministry of Health of Kuwait, approved on the 12th February 2009 (ref: MPH/112)
Study design Assessor blinded two arm randomised controlled trial
Countries of recruitment Kuwait
Disease/condition/study domain Obesity
Participants - inclusion criteria 1. Boys and girls
2. Obese (body mass index [BMI] at or above 95th percentile on US CDC 200 BMI charts)
3. Aged 10 - 14 years inclusive
4. With no major chronic disease or disability
5. With no obvious underlying pathological cause of obesity
6. At least one parent willing to attend treatment sessions if randomly allocated to intervention
7. Attending a mainstream school in the public sector
Participants - exclusion criteria 1. Non-obese
2. With major disease
3. With underlying pathological cause of obesity
4. Less than 10 years or greater than 14 years at study inception
5. Not attending a mainstream school in the public sector
6. Unable or unwilling to attend treatment sessions if randomised to intervention group
Anticipated start date 11/11/2009
Anticipated end date 31/12/2010
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 100 - 140 at study entry
Interventions Random allocation to intervention or standard care control group:
1. Standard care control: referral to primary care, where treatment will be limited to a little health education
2. Intervention group: invited to 10 session of behavioural change counselling targeted at changes in physical activity, diet, and sedentary behaviour, over a 24 - 26 week period

Of the 10 sessions, five will be delivered by a dietician, five by a physician. Sessions 1 - 8 fortnightly for first 16 weeks, session 9 at week 20 and session 10 at week 26.
Primary outcome measure(s) Change in BMI z score from baseline to 6 months after the start of treatment or standard care control.
Secondary outcome measure(s) 1. Change in quality of life from baseline to +6 month follow up
2. Change in blood pressure and blood-based cardiometabolic risk factors (fasting lipids, triglycerides, insulin, glucose) from baseline to +6 months
3. Changes in estimated fat and fat free mass from baseline to +6 month follow up (using bioelectrical impedance)
Sources of funding Civil Service Commission (Kuwait)
Trial website
Publications
Contact name Prof  John  Reilly
  Address University of Glasgow Division of Developmental Medicine
1st Floor Tower QMH
Yorkhill Hospitals
  City/town Glasgow
  Zip/Postcode G3 8SJ
  Country United Kingdom
Sponsor Civil Service Commission (Kuwait)
  Address Scholarships Department
State of Kuwait
  City/town Kuwait City
  Zip/Postcode KCL889
  Country Kuwait
  Sponsor website: http://www.csc.net.kw/
Date applied 09/10/2009
Last edited 01/12/2009
Date ISRCTN assigned 01/12/2009
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 ISRCTN unless otherwise stated.


BioMed Central